Demant A/S

CPSE:DEMANT Stock Report

Market Cap: DKK 56.4b

Demant Valuation

Is DEMANT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DEMANT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DEMANT (DKK265.4) is trading below our estimate of fair value (DKK494.95)

Significantly Below Fair Value: DEMANT is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DEMANT?

Key metric: As DEMANT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for DEMANT. This is calculated by dividing DEMANT's market cap by their current earnings.
What is DEMANT's PE Ratio?
PE Ratio22.8x
EarningsDKK 2.54b
Market CapDKK 56.39b

Price to Earnings Ratio vs Peers

How does DEMANT's PE Ratio compare to its peers?

The above table shows the PE ratio for DEMANT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average55.4x
AMBU B Ambu
121.5x27.0%DKK 28.6b
EMBLA Embla Medical hf
30.7x16.9%DKK 15.1b
COLO B Coloplast
35.7x11.8%DKK 180.3b
TFX Teleflex
33.7x22.8%US$8.3b
DEMANT Demant
22.8x12.4%DKK 57.8b

Price-To-Earnings vs Peers: DEMANT is good value based on its Price-To-Earnings Ratio (22.8x) compared to the peer average (55.7x).

Price to Earnings Ratio vs Industry

How does DEMANT's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
DEMANT 22.8xIndustry Avg. 29.4xNo. of Companies9PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: DEMANT is good value based on its Price-To-Earnings Ratio (22.8x) compared to the European Medical Equipment industry average (29.4x).

Price to Earnings Ratio vs Fair Ratio

What is DEMANT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DEMANT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.8x
Fair PE Ratio32.5x

Price-To-Earnings vs Fair Ratio: DEMANT is good value based on its Price-To-Earnings Ratio (22.8x) compared to the estimated Fair Price-To-Earnings Ratio (32.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DEMANT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentDKK 265.40
DKK 296.82
+11.8%
10.4%DKK 350.00DKK 245.00n/a17
Dec ’25DKK 269.20
DKK 296.41
+10.1%
10.5%DKK 350.00DKK 245.00n/a17
Nov ’25DKK 260.60
DKK 302.41
+16.0%
10.4%DKK 360.00DKK 250.00n/a17
Oct ’25DKK 261.20
DKK 301.31
+15.4%
11.1%DKK 370.00DKK 250.00n/a16
Sep ’25DKK 285.60
DKK 303.81
+6.4%
11.6%DKK 370.00DKK 230.00n/a16
Aug ’25DKK 263.00
DKK 314.94
+19.7%
13.9%DKK 381.00DKK 230.00n/a16
Jul ’25DKK 301.80
DKK 336.69
+11.6%
14.1%DKK 400.00DKK 268.00n/a16
Jun ’25DKK 329.00
DKK 337.31
+2.5%
14.3%DKK 400.00DKK 268.00n/a16
May ’25DKK 321.00
DKK 334.75
+4.3%
15.5%DKK 400.00DKK 240.00n/a16
Apr ’25DKK 343.00
DKK 339.47
-1.0%
15.8%DKK 405.00DKK 240.00n/a17
Mar ’25DKK 353.30
DKK 336.53
-4.7%
15.1%DKK 400.00DKK 240.00n/a17
Feb ’25DKK 317.60
DKK 298.71
-5.9%
13.5%DKK 355.00DKK 235.00n/a17
Jan ’25DKK 296.00
DKK 288.71
-2.5%
15.1%DKK 350.00DKK 185.00n/a17
Dec ’24DKK 282.30
DKK 286.76
+1.6%
13.4%DKK 335.00DKK 185.00DKK 269.2017
Nov ’24DKK 272.10
DKK 287.69
+5.7%
15.4%DKK 340.00DKK 185.00DKK 260.6016
Oct ’24DKK 292.60
DKK 286.47
-2.1%
15.8%DKK 340.00DKK 185.00DKK 261.2015
Sep ’24DKK 285.20
DKK 285.94
+0.3%
15.4%DKK 340.00DKK 185.00DKK 285.6016
Aug ’24DKK 265.70
DKK 264.27
-0.5%
19.1%DKK 330.00DKK 180.00DKK 263.0015
Jul ’24DKK 288.50
DKK 256.60
-11.1%
20.2%DKK 330.00DKK 180.00DKK 301.8015
Jun ’24DKK 269.50
DKK 252.13
-6.4%
20.9%DKK 330.00DKK 180.00DKK 329.0015
May ’24DKK 292.40
DKK 230.79
-21.1%
19.4%DKK 330.00DKK 180.00DKK 321.0014
Apr ’24DKK 240.20
DKK 222.00
-7.6%
13.2%DKK 275.00DKK 180.00DKK 343.0013
Mar ’24DKK 210.00
DKK 218.00
+3.8%
14.8%DKK 275.00DKK 180.00DKK 353.3014
Feb ’24DKK 198.10
DKK 206.50
+4.2%
13.7%DKK 254.00DKK 170.00DKK 317.6014
Jan ’24DKK 192.55
DKK 215.23
+11.8%
16.7%DKK 285.00DKK 165.00DKK 296.0013
Dec ’23DKK 206.20
DKK 215.25
+4.4%
17.2%DKK 285.00DKK 165.00DKK 282.3012

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 19:15
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Demant A/S is covered by 50 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Morten LarsenABG Sundal Collier
Pierre-Yves GauthierAlphaValue
Gina FrancioliBank am Bellevue